NCT04233593View on ClinicalTrials.gov

Neuroimmune Response to Lipopolysaccharide

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 25, 2014

Primary Completion Date

August 17, 2021

Study Completion Date

August 17, 2021

Conditions
Healthy
Interventions
BIOLOGICAL

Lipopolysaccharide

Endotoxin E Coli

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04233593 - Neuroimmune Response to Lipopolysaccharide | Biotech Hunter | Biotech Hunter